492 related articles for article (PubMed ID: 20464716)
1. Speech and language therapy for aphasia following stroke.
Kelly H; Brady MC; Enderby P
Cochrane Database Syst Rev; 2010 May; (5):CD000425. PubMed ID: 20464716
[TBL] [Abstract][Full Text] [Related]
2. Speech and language therapy for aphasia following stroke.
Brady MC; Kelly H; Godwin J; Enderby P
Cochrane Database Syst Rev; 2012 May; (5):CD000425. PubMed ID: 22592672
[TBL] [Abstract][Full Text] [Related]
3. Speech and language therapy for aphasia following stroke.
Brady MC; Kelly H; Godwin J; Enderby P; Campbell P
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD000425. PubMed ID: 27245310
[TBL] [Abstract][Full Text] [Related]
4. Transcranial direct current stimulation (tDCS) for improving aphasia in adults with aphasia after stroke.
Elsner B; Kugler J; Pohl M; Mehrholz J
Cochrane Database Syst Rev; 2019 May; 5(5):CD009760. PubMed ID: 31111960
[TBL] [Abstract][Full Text] [Related]
5. Speech and language therapy for aphasia following stroke.
Greener J; Enderby P; Whurr R
Cochrane Database Syst Rev; 2000; (2):CD000425. PubMed ID: 10796360
[TBL] [Abstract][Full Text] [Related]
6. Transcranial direct current stimulation (tDCS) for improving aphasia in patients with aphasia after stroke.
Elsner B; Kugler J; Pohl M; Mehrholz J
Cochrane Database Syst Rev; 2015 May; (5):CD009760. PubMed ID: 25929694
[TBL] [Abstract][Full Text] [Related]
7. Transcranial direct current stimulation (tDCS) for improving aphasia in patients after stroke.
Elsner B; Kugler J; Pohl M; Mehrholz J
Cochrane Database Syst Rev; 2013 Jun; (6):CD009760. PubMed ID: 23799617
[TBL] [Abstract][Full Text] [Related]
8. Computerised speech and language therapy or attention control added to usual care for people with long-term post-stroke aphasia: the Big CACTUS three-arm RCT.
Palmer R; Dimairo M; Latimer N; Cross E; Brady M; Enderby P; Bowen A; Julious S; Harrison M; Alshreef A; Bradley E; Bhadhuri A; Chater T; Hughes H; Witts H; Herbert E; Cooper C
Health Technol Assess; 2020 Apr; 24(19):1-176. PubMed ID: 32369007
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological treatment for aphasia following stroke.
Greener J; Enderby P; Whurr R
Cochrane Database Syst Rev; 2001; 2001(4):CD000424. PubMed ID: 11687079
[TBL] [Abstract][Full Text] [Related]
10. Attention control comparisons with SLT for people with aphasia following stroke: methodological concerns raised following a systematic review.
Brady MC; Godwin J; Kelly H; Enderby P; Elders A; Campbell P
Clin Rehabil; 2018 Oct; 32(10):1383-1395. PubMed ID: 29911416
[TBL] [Abstract][Full Text] [Related]
11. FCET2EC (From controlled experimental trial to = 2 everyday communication): How effective is intensive integrative therapy for stroke-induced chronic aphasia under routine clinical conditions? A study protocol for a randomized controlled trial.
Baumgaertner A; Grewe T; Ziegler W; Floel A; Springer L; Martus P; Breitenstein C
Trials; 2013 Sep; 14():308. PubMed ID: 24059983
[TBL] [Abstract][Full Text] [Related]
12. Dosage, Intensity, and Frequency of Language Therapy for Aphasia: A Systematic Review-Based, Individual Participant Data Network Meta-Analysis.
REhabilitation and recovery of peopLE with Aphasia after StrokE (RELEASE) Collaborators
Stroke; 2022 Mar; 53(3):956-967. PubMed ID: 34847708
[TBL] [Abstract][Full Text] [Related]
13. Precision rehabilitation for aphasia by patient age, sex, aphasia severity, and time since stroke? A prespecified, systematic review-based, individual participant data, network, subgroup meta-analysis.
; Brady MC; Ali M; VandenBerg K; Williams LJ; Williams LR; Abo M; Becker F; Bowen A; Brandenburg C; Breitenstein C; Bruehl S; Copland DA; Cranfill TB; Pietro-Bachmann MD; Enderby P; Fillingham J; Lucia Galli F; Gandolfi M; Glize B; Godecke E; Hawkins N; Hilari K; Hinckley J; Horton S; Howard D; Jaecks P; Jefferies E; Jesus LM; Kambanaros M; Kyoung Kang E; Khedr EM; Pak-Hin Kong A; Kukkonen T; Laganaro M; Lambon Ralph MA; Charlotte Laska A; Leemann B; Leff AP; Lima RR; Lorenz A; MacWhinney B; Shisler Marshall R; Mattioli F; Maviş İ; Meinzer M; Nilipour R; Noé E; Paik NJ; Palmer R; Papathanasiou I; Patricio B; Pavão Martins I; Price C; Prizl Jakovac T; Rochon E; Rose ML; Rosso C; Rubi-Fessen I; Ruiter MB; Snell C; Stahl B; Szaflarski JP; Thomas SA; van de Sandt-Koenderman M; van der Meulen I; Visch-Brink E; Worrall L; Harris Wright H
Int J Stroke; 2022 Dec; 17(10):1067-1077. PubMed ID: 35422175
[TBL] [Abstract][Full Text] [Related]
14. Augmentative and alternative communication intervention for in-patient individuals with post-stroke aphasia: study protocol of a parallel-group, pragmatic randomized controlled trial.
Huang L; Chen SK; Xu S; Wang Y; Jin X; Wan P; Sun J; Tao J; Zhang S; Zhang G; Shan C
Trials; 2021 Nov; 22(1):837. PubMed ID: 34819130
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of transcranial direct current stimulation (tDCS) combined with speech language therapy (SLT) on post-stroke aphasia patients: A systematic review and network meta-analysis of randomized controlled trials.
You Y; Li Y; Zhang Y; Fan H; Gao Q; Wang L
NeuroRehabilitation; 2023; 53(3):285-296. PubMed ID: 37781820
[TBL] [Abstract][Full Text] [Related]
16. Interventions for apraxia of speech following stroke.
West C; Hesketh A; Vail A; Bowen A
Cochrane Database Syst Rev; 2005 Oct; 2005(4):CD004298. PubMed ID: 16235357
[TBL] [Abstract][Full Text] [Related]
17. Speech and language therapy for dysarthria due to non-progressive brain damage.
Sellars C; Hughes T; Langhorne P
Cochrane Database Syst Rev; 2005 Jul; (3):CD002088. PubMed ID: 16034872
[TBL] [Abstract][Full Text] [Related]
18. Timing of transcranial direct current stimulation (tDCS) combined with speech and language therapy (SLT) for aphasia: study protocol for a randomized controlled trial.
Ashaie SA; Engel S; Cherney LR
Trials; 2022 Aug; 23(1):668. PubMed ID: 35978374
[TBL] [Abstract][Full Text] [Related]
19. Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting.
Breitenstein C; Grewe T; Flöel A; Ziegler W; Springer L; Martus P; Huber W; Willmes K; Ringelstein EB; Haeusler KG; Abel S; Glindemann R; Domahs F; Regenbrecht F; Schlenck KJ; Thomas M; Obrig H; de Langen E; Rocker R; Wigbers F; Rühmkorf C; Hempen I; List J; Baumgaertner A;
Lancet; 2017 Apr; 389(10078):1528-1538. PubMed ID: 28256356
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
